JULVIA  Technologies Inc. has developed a platform for superficial wound closure and management. Patent pending and Class I (510k exempt), our SUTUREGARD™ wound closure devices secure sutures using common equipment, require minimal skill, and allow non-absorbable sutures to be retained in wounds much longer than normal nonabsorbable sutures. Data from our biomechanical and pre-clinical research reveals that the mattress SUTUREGARD ™ device is:

  • easily and quickly removed at up to 6 weeks days post-injury;
  • less traumatic to skin wound edges;
  • effective in maintaining wound closures for 42 days that are 680% stronger than wounds with supports removed at 10 days;
  • well tolerated with no adverse gross or microscopic effects on the wound or skin;
  • promotes skin eversion

 


Legal Disclaimer: The statements one this website have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.